Immunic investor relations

Author: jzlk

August undefined, 2024

WitrynaAll Events Quarterly Earnings Healthcare Conferences Other Investor Events. 03.07.2024. Cowen 43rd Annual Health Care Conference. Presentation. Transcript. Webcast. 02.16.2024. SVB Securities Global Biopharma Conference. Transcript. WitrynaNeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing innovative treatments for chronic liver and related metabolic diseases. NeuroBo has clinical programs targeting non-alcoholic steatohepatitis (NASH), obesity, and Type 2 diabetes. Our strategic partner and the largest shareholder, Dong-A ST …

Immunic, Inc. to Participate in Upcoming Investor and Industry ...

Witryna23 lut 2024 · Immunic, Inc. (NASDAQ:NASDAQ:IMUX) Q4 2024 Earnings Conference Call February 23, 2024 8:00 AM ETCompany ParticipantsJessica Breu - Head, IR & CommunicationsDaniel Vitt - CEO, President... WitrynaImmunic Therapeutics has raised a total of $284.4M in funding over 9 rounds. Their latest funding was raised on Oct 10, 2024 from a Post-IPO Equity round. Immunic Therapeutics is registered under the ticker NASDAQ:IMUX . Immunic Therapeutics is funded by 21 investors. Vivo Capital and RTW Investments are the most recent … datacamp data science with python

Vistra Corp. Investor Relations - SEC Filings

Witryna4 paź 2024 · Members of Immunic's business development and investor relations teams will attend this conference in Leipzig, ... Head of Investor Relations and Communications +49 89 2080 477 09 Witryna26 lut 2024 · /PRNewswire/ -- Immunic, Inc. (Nasdaq: ... Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] US IR Contact Rx … Witryna5 kwi 2024 · Immunic is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and … datacamp data analysis in excel review

Immunic gets a "positive surprise" from lead asset trial

Witryna11 kwi 2024 · The trading price of Immunic Inc. (NASDAQ:IMUX) closed lower on Monday, April 10, closing at $1.33, -4.32% lower than its previous close. In examining … Witryna28 lip 2024 · Q1 2024 Athenex Inc. Earnings Conference Call. Monday, March 01, 2024 8:00 am EST. Q4 and Full Year 2024 Athenex, Inc. Earnings Conference Call. Monday, January 11, 2024 8:40 am EST. ATNX at 39th Annual J.P. Morgan Healthcare Conference. Wednesday, December 09, 2024 5:00 pm EST. bitlocker login pageWitryna24 lut 2024 · /PRNewswire/ -- Immunic, Inc. (Nasdaq: ... Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] US IR Contact Rx Communications Group Paula Schwartz data camp business analyst course

"Witryna1 wrz 2024 · Daniel Vitt, Ph.D., Chief Executive Officer and President of Immunic, and Jessica Breu, Head of Investor Relations and Communications at Immunic, will … " - Immunic investor relations

Immunic investor relations

Witryna6 lip 2024 · Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune ... WitrynaWednesday, June 16, 2024 10:00 AM EDT. Eyenovia Inc. First Quarter 2024 Earnings Call. Wednesday, May 12, 2024 4:30 PM EDT. Eyenovia Inc. Fourth Quarter 2024 Earnings Call. Thursday, March 25, 2024 4:30 PM EDT. 33rd Annual Roth Conference. Monday, March 15 - Wednesday, March 17, 2024.

Did you know?

WitrynaManager Investor Relations and Communications Immunic AG. 2 Jahre und 6 Monate, Mai 2016 - Okt. 2024. Junior Consultant Public and Investor Relations MC Services AG. 1 Jahr und 2 Monate, März … Witryna29 kwi 2016 · About Immunic. Immunic AG (www.immunic.de) is a start-up biotech company founded in April 2016 and focused on the development of immune modulators to block Th17- and Th1-mediated immune and autoimmune responses. The company’s two development programs include orally available, small molecule inhibitors of …

Witryna10 paź 2024 · Immunic expressly disclaims all liability in respect to actions taken or not taken based on any or all the contents of this press release. Contact Information Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]. Rx Communications Group Paula Schwartz +1 … Witryna8 mar 2024 · Archived Events. Date. Event Details. Mar 8, 2024 10:30 AM EST. 43rd Annual Cowen Health Care Conference. Listen to webcast. Feb 6, 2024 4:30 PM EST. Arrowhead Pharmaceuticals 2024 First Quarter Results. Listen to webcast.

Witryna12 kwi 2024 · For Institutional Investors, Securities Analysts. Phone line：+81-3-3244-3022. Business hours (JST): From Monday to Thursday: 8:45 am to 5:45 pm, Friday: 8:45 am to 4:00 pm (closed on Saturdays, Sundays, national holidays and company holidays) Witryna3 lis 2024 · Immunic expressly disclaims all liability in respect to actions taken or not taken based on any or all the contents of this press release. Contact Information. Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]. US IR Contact Rx Communications Group …

Witryna17 lis 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]. US IR Contact Rx Communications Group Melody Carey +1 917 322 2571 [email protected]. US Media Contact KOGS Communication Edna Kaplan +1 781 639 1910 [email protected]

Witryna23 lut 2024 · /PRNewswire/ -- Immunic, Inc. (NASDAQ: ... Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] US IR Contact Rx … datacamp data scientist with pythonWitryna3 lis 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] US IR Contact Rx … datacamp customer service phone numberWitryna6 lis 2024 · Immunic, Inc. (NASDAQ:NASDAQ:IMUX) Q3 2024 Earnings Conference Call November 3, 2024 8:00 AM ETCompany ParticipantsJessica Breu - Head, IR and CommunicationsDaniel Vitt - CEO and... bitlocker login microsoftWitrynaImmunic is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune … datacamp data analyst with pythonWitryna6 lis 2024 · Immunic, Inc. (NASDAQ:NASDAQ:IMUX) Q3 2024 Earnings Conference Call November 3, 2024 8:00 AM ETCompany ParticipantsJessica Breu - Head, IR and … bitlocker login loopWitryna26 lut 2024 · Immunic expressly disclaims all liability in respect to actions taken or not taken based on any or all the contents of this press release. Contact Information. Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]. US IR Contact Rx Communications Group … bitlocker logon screenWitryna3 lis 2024 · Immunic expressly disclaims all liability in respect to actions taken or not taken based on any or all the contents of this press release. Contact Information Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] datacamp failed to authenticate